Effect of down-regulation of fatty acid synthase expression on proliferation, migration and invasion of bladder carcinoma UMUC3 cell lines

doi:10.12047/j.cjap.5868.2019.119

Abstract

Abstract: Objective: To investigate the effects of fatty acid synthase (FASN) on proliferation, migration and invasion of bladder cancer UMUC3 cell lines and possible mechanism. Methods: The expression levels of FASN protein in 30 cases of bladder cancer and 15 cases of normal bladder tissues were detected by Immunohistochemistry. FASN siRNA and nonsense siRNA were transfected into UMUC3 cell lines by lipofectamine 2000 respectively, and the stable siFASN and siControl cell lines were successfully obtained after screening and identification for several times. The siFASN cell lines were set as the experimental group, while the siControl cell lines were set as the control group. The expressions of FASN protein and mRNA in the experimental group and the control group were detected by Western blot and real-time quantitative PCR (RT-PCR) respectively. Cell proliferation activities in two groups were detected by MTT assay and cell invasion and migration in two groups were detected by cell scratch test and Transwell invasive assays respectively. Results: FASN protein was overexpressed in bladder cancer tissues, and it was closely correlated with pathological stage and grade (P＜0.05). Compared with the siControl group, the expressions of FASN mRNA and protein in the siFASN group cell lines were decreased significantly (P＜0.05). The cell proliferation ability, the migration ability and the number of transmembrane cells of siFASN group cell lines were reduced significantly (P＜0.05). Conclusion: The FASN overexpression may play an essential role in the development and progression of bladder cancer. Down-regulation of FASN expression can inhibit the proliferation, migration and invasion of bladder cancer cells, and inhibition of FASN expression is expected to be a new treatment for bladder cancer.

Key words: fatty acid synthase, bladder cancer, cell proliferation, cell invasion, cell migration

CLC Number:

YAN Xin-jian, LI Gao-feng, TANG Mei, YANG Xiao-ping. Effect of down-regulation of fatty acid synthase expression on proliferation, migration and invasion of bladder carcinoma UMUC3 cell lines[J]. CJAP, 2019, 35(6): 543-547.

References

[1] Babjuk M. Trends in bladder cancer incidence and mortality: success or disappointment[J]? Eur Urol, 2017, 71(1): 109-110.
[2] Allina DO, Andreeva YY, Zavalishina LE, et al. Fatty acid synthase in the diagnosis of prostate neoplasms[J]. Arkh Patol, 2017, 79(2): 10-14.
[3] Giró-Perafita A, Sarrats A, Pérez-Bueno F, et al. Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer[J]. Oncotarget, 2017, 8(43): 74391-74405.
[4] Lee KH, Lee MS, Cha EY, et al. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis[J]. Mol Med Rep, 2017, 15(4): 2163-2173.
[5] Bian Y, Yu Y, Wang S, et al. Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer[J]. Biochem Biophys Res Commun, 2015, 463(4): 612-617.
[6] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[7] Danhier P, Bański P, Payen VL, et al. Cancer metabolism in space and time: beyond the warburg effect[J]. Biochim Biophys Acta Bioenerg, 2017:. S0005272817300233.
[8] Hopperton KE, Duncan RE, Bazinet RP, et al. Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity[J]. Exp Cell Res, 2014, 320(2): 302-310.
[9] Jones SF, Infante JR. Molecular pathways: fatty acid synthase[J]. Clin Cancer Res, 2015, 21(24): 5434-5438.
[10]Sun L, Yao Y, Pan G, et al. Small interfering RNA-mediated knockdown of fatty acid synthase attenuates the proliferation and metastasis of human gastric cancer cells via the mTOR/Gli1 signaling pathway[J]. Oncol Lett, 2018, 16(1): 594-602.
[11]Gong J, Shen S, Yang Y, et al. Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway[J]. Int J Oncol, 2017, 50(3): 883-892.
[12]邓雷弘, 徐芳华, 董志峰, 等. FASN在膀胱癌组织中的表达及其临床意义[J]. 临床泌尿外科杂志, 2018, 33(3): 203-207.
[13]Chang L, Wu P, Senthikumar R, et al. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway[J]. J Cancer Res and Clin Oncol, 2016, 142(1): 59-72.
[14]Long X, Zhang G, Peng A. et al. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro[J]. Oncol Rep, 2014, 31(1): 328-334.
[15]凌宏艳, 贺娟, 杨丝丝, 等. 槟榔碱对3T3-L1脂肪细胞脂代谢的影响[J]. 中国应用生理学杂志, 2017, 33(1): 22-25.
[16]Falchook G, Patel M, Infante J, et al. Abstract CT153: First in human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640[J]. Cancer Res, 2017, 77(13 Supplement): CT153-CT153.